Gastrointestinal Disorder Monitoring
Gastrointestinal Disorder Monitoring - Related Videos
08:15
Gastrointestinal Motility Monitor (GIMM)
0 Views •
Cited by 36 •
2010
Evaluation of colonic motility in the guinea pig distal colon with the Gastrointestinal Motility Monitor (GIMM) is a straightforward and simple to learn approach to quantitatively evaluate propulsive motility in the gastrointestinal tract.
01:20
Gastrointestinal Motility Disorders
0 Views •
2024
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
06:02
Isolation of CD 90+ Fibroblast/Myofibroblasts from Human Frozen Gastrointestinal Specimens
0 Views •
Cited by 17 •
2016
Here, a protocol to isolate and establish primary fibroblast/myofibroblast (MF) cultures from frozen gastric, small intestinal, and colonic tissue-yielding cells with a MF phenotype-is presented. These cells express CD90, α-SMA and vimentin. MFs can be used for a variety of functional assays including enzymatic activity and cytokine production.
06:04
Ex Vivo Intestinal Sacs to Assess Mucosal Permeability in Models of Gastrointestinal Disease
0 Views •
Cited by 41 •
2016
This protocol describes the use of excised intestinal tissue preparations or "intestinal sacs" as an ex vivo model of intestinal barrier function. This model may be used to assess integrity of both the epithelial barrier and the mucous gel layer at specific intestinal sites in animal models of digestive disease.
01:26
Anatomy of the Gastrointestinal System
0 Views •
2025
The human digestive system is an intricate and essential network for nutrient absorption and waste elimination. It encompasses the gastrointestinal (GI) tract and several accessory organs. Here's a detailed walkthrough of this complex system: Oral Cavity: The starting point of the digestive process. It comprises lips, cheeks, teeth, and salivary glands within mucous membranes. It extends to the soft palate, the floor of the mouth, and the tongue. Pharynx: It is a tubular...
FAQs
Its strength comes from combining complementary evidence rather than relying on symptoms alone. Clinical observations indicate how the patient feels and functions, while inflammatory biomarkers, microbiological tests, imaging, and tissue analysis provide objective views of intestinal activity. Comparing these signals over repeated assessments can reveal whether changes reflect inflammation, infection, or improvement.
The approach separates two potentially overlapping explanations for gastrointestinal abnormalities by examining both inflammatory activity and evidence of pathogens. Inflammatory biomarkers, imaging, or tissue analysis can document mucosal inflammation, while microbiological testing evaluates infectious causes. Considering these findings alongside clinical symptoms helps researchers and clinicians relate intestinal changes to immune responses or infection.
Repeated assessments show whether gastrointestinal abnormalities are stable, worsening, recurring, or improving. A single observation may capture only one point in the disease course, whereas longitudinal data connect changes in symptoms, inflammatory findings, pathogen testing, imaging, or tissue results over time. This pattern supports evaluation of treatment response and investigation of disease mechanisms.
Monitoring may collect clinical symptoms together with objective measures selected from inflammatory biomarkers, microbiological testing for pathogens, imaging, and tissue analysis. These sources address different aspects of digestive-tract status, including mucosal inflammation and infection. Repeating the assessments creates a structured record that can be compared across disease progression, recurrence, or treatment.
It is useful when investigators need to follow intestinal changes while studying host defenses, immune-mediated disease, or infectious processes. The approach can help identify worsening or recurrence, distinguish immune activity from pathogen-associated findings, and connect clinical changes with biological measurements. Longitudinal monitoring also supplies data for evaluating how disease mechanisms and therapeutic effectiveness develop over time.
Results can show whether disease activity is increasing, recurring, or responding to treatment, which supports more informed and safer care decisions. In research, the same observations provide outcome measures for therapeutic studies and longitudinal evidence about disease behavior. Interpreting symptoms together with objective findings reduces reliance on any single signal when assessing progress.